Potassium Carbonate → HCID 57443120, compound
Reaction equation
[CH:1]1([N:5]2[CH2:10][CH2:9][N:8]([C:11](=[O:19])[CH2:12][N:13]3[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]3)[CH2:7][CH2:6]2)[CH2:4][CH2:3][CH2:2]1.[Cl:20][C:21]1[N:22]=[N:23][C:24](Cl)=[CH:25][CH:26]=1.C([O-])([O-])=O.[K+].[K+]>CS(C)=O>[Cl:20][C:21]1[N:22]=[N:23][C:24]([N:16]2[CH2:15][CH2:14][N:13]([CH2:12][C:11]([N:8]3[CH2:9][CH2:10][N:5]([CH:1]4[CH2:2][CH2:3][CH2:4]4)[CH2:6][CH2:7]3)=[O:19])[CH2:18][CH2:17]2)=[CH:25][CH:26]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Dissolve 1-cyclobutyl-4-(piperazin-1-ylacetyl)piperazine (2.05 g, 5.46 mmol) and 3,6-dichloropyridazine (810 mg, 5.46 mmol) in dry DMSO (25 mL). Add K2CO3 (3.77 g, 27.3 mmol) and heat the mixture at 120° C. overnight. Cool and partition between CH2Cl2 (100 mL) and 1 N NaOH (150 mL). Extract the aqueous phase with CH2Cl2 (2×100 mL). Combine, dry and evaporate the organic extracts. Triturate the resulting residue with ether and filter off the solid (product). Evaporate the filtrate and chromatograph the resulting residue with EtOAc followed by EtOAc/MeOH (95:5) and EtOAc/MeOH/TEA(95:5:5) to yield additional product. 1H NMR (CDCl3) δ 7.21 (d, 1H), 6.89 (d, 1H), 3.68-3.59 (m, 8H), 3.22 (s, 2H), 2.78-2.62 (m, 5H), 2.38-2.28 (m, 4H), 2.13-2.03 (m, 2H), 1.93-1.8 (m, 2H), 1.73-1.69 (m, 2H); LC-MS (M+1) 378.98.
Workup
- temperatureCool
- custompartition between CH2Cl2 (100 mL) and 1 N NaOH (150 mL)
- extractionExtract the aqueous phase with CH2Cl2 (2×100 mL)
- customCombine, dry
- customevaporate the organic extracts
- customTriturate the resulting residue with ether
- filtrationfilter off the solid (product)
- customEvaporate the filtrate and chromatograph the resulting residue with EtOAc
- customto yield additional product
Sources & evidence
- ORD record
- ord-6bf5eb30237c41a39ef64abac19e470c
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07851474B2
Reaction notes
Loading…